IOP, Inc., headquartered in Costa Mesa, California, is an innovation-driven, medical technology company, providing specialty ophthalmic surgical devices worldwide. IOP, Inc. develops, commercializes and distributes a wide range of technologies to the oculoplastic, glaucoma and cornea subspecialty markets.

IOP, Inc., founded in 1988, is focused on leading-edge surgical technologies. IOP, Inc. has leadership positions with bioimplants and devices for ophthalmic plastic and reconstructive surgeries; glaucoma implant drainage technology; and bioimplants for a wide range of ophthalmic surgical applications.

Through intimate relationships with key clinical and market leaders, IOP, Inc. has an established and focused technology-development pipeline. The Company believes it will lead to differentiated, unique technologies that will satisfy unmet surgeon and patient demands.

IOP, Inc. uses a variety of innovative methods and strategic collaborations to develop and deliver technologies offering solutions. The Company has formed and currently maintains strategic alliances with OKTO Ophtho, Tutogen Medical, Inc., Molteno® Ophthalmic Ltd., Advanced Meditech International Inc. and Osmed GbH.

The Company is a subsidiary of ARXA 5 Corporation (privately-held California S-corporation).